Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kirubanandhan, Lokeshwaran"'
Autor:
Chandy, Sara1, Kirubanandhan, Lokeshwaran2, Hemavathy, Priya3, Khadeeja, Anees Mohammad3, Kurian, Siby Jacob3, Venkataraman, Krishnan2, Mørch, Kristine4, Mathai, Dilip5, Manoharan, Anand1
Publikováno v:
Journal of Infection in Developing Countries. Mar2017, Vol. 11 Issue 3, p234-241. 8p.
Autor:
Kirubanandhan, Lokeshwaran, Audrey, Hemadou, N S, Jayaprakash, R R, Prasanna, Marie-Josée, Jacobin-Valat, Wilfrid, Dieryck, Gilles, Joucla, M A, Vijayalakshmi, Gisèle, Clofent-Sanchez, Xavier, Santarelli, Krishnan, Venkataraman
Publikováno v:
Journal of immunological methods. 474
High density lipoproteins (HDL) are considered cardio protective. Apolipoprotein A-I (apoA-I), a major component of HDL helps in reverse cholesterol transport, whose function is greatly affected during atherosclerosis due to oxidation by myeloperoxid
Autor:
Gilles Joucla, Marie-Josée Jacobin-Valat, Xavier Santarelli, Krishnan Venkataraman, Rajasekar R. Prasanna, Mookambeswaran A. Vijayalakshmi, N. S. Jayaprakash, Kirubanandhan Lokeshwaran, Wilfrid Dieryck, Audrey Hemadou, Gisèle Clofent-Sanchez
Publikováno v:
Journal of Immunological Methods
Journal of Immunological Methods, Elsevier, 2019, 474, pp.112637. ⟨10.1016/j.jim.2019.112637⟩
Journal of Immunological Methods, Elsevier, 2019, 474, pp.112637. ⟨10.1016/j.jim.2019.112637⟩
High density lipoproteins (HDL) are considered cardio protective. Apolipoprotein A-I (apoA-I), a major component of HDL helps in reverse cholesterol transport, whose function is greatly affected during atherosclerosis due to oxidation by myeloperoxid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6720732196e11f43b4efa9e17d193fb5
http://hdl.handle.net/20.500.12278/7555
http://hdl.handle.net/20.500.12278/7555
Publikováno v:
Protein & Peptide Letters. 23:905-912
ApoAI, a major protein component of HDL is considered to be a key factor which contributes for HDL's cardio- protective functions. ApoAI is sensitive to myeloperoxidase mediated oxidative modifications under chronic inflammatory conditions such as at